William B. Stilley III - Feb 23, 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer, Director
Signature
/s/ William B. Stilley, III
Stock symbol
ADIL
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 02:00 PM
Previous filing
Dec 1, 2021
Next filing
Aug 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Award $0 +250K +26.66% $0.00 1.19M Feb 23, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date.